Cell therapy
These companies develop treatments made from living cells, such as engineered immune cells and stem cells.
−4.5%
over 1 year · S&P 500 +11.6%
Key indicators
Health
44 / 100
Fragile
Solid
Up over 1 year
6 of 15
Volatility
83%
Calm
Choppy
Profitability
−127%
Low
High
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 17 companies
LEGN
−43.9%
IOVA
+205.5%
VCEL
+40.9%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
L
Legend Biotech
LEGN
26.4%
−43.9%
I
Iovance Biotherapeutics
IOVA
25.1%
+205.5%
V
Vericel
VCEL
19.4%
+40.9%
O
Obsidian Therapeutics
OBX
5.3%
S
Sana Biotechnology
SANA
5.1%
−50.2%
I
Immix Biopharma
IMMX
4.8%
+110.8%
C
Capricor Therapeutics
CAPR
3.9%
+62.4%
C
Cabaletta Bio
CABA
2.2%
−47.8%
A
Allogene Therapeutics
ALLO
2.1%
−31.8%
K
Kyverna Therapeutics
KYTX
2.1%
−31.1%
A
Artiva Biotherapeutics
ARTV
1.3%
+0.8%
F
Fate Therapeutics
FATE
1.0%
+23.1%
A
Abeona Therapeutics
ABEO
0.9%
−51.0%
A
Adicet Bio
ACET
0.2%
−74.7%
A
Aspen Neuroscience
ASPE
A
Autolus Therapeutics
AUTL
−14.0%
M
Mesoblast
MESO
−15.5%